Meet Our Silo-Busting Attendees

​Our audience cuts across sectors and disciplines for a multi-pronged approach to one of the most important health issues affecting people in all walks of life.

• Healthcare - Administrators, clinicians, and patient advocates interested in the prevention and delay of illness and aging
• Preclinical Research - Scientists involved in metabolic, cancer, dementia, cardiovascular and aging-related research
• Clinical Research - Investigators and healthcare providers involved in chronic non-communicable disease care and prevention
• Industry -  Corporate leaders and startups that are developing pharmaceutical, digital health, nutrition, new business models and other approaches to disease prevention and healthy aging
• Finance - Funders, payers and investors (including capital markets, philanthropies, government and insurers) in disease prevention and healthy aging
• Policy and Law - Government regulators, policy makers, elected officials, and advisors involved in Healthspan equity and the future of Healthspan
• Social Justice - Equity groups, social change agents, and philanthropic organizations interested in broadening access to healthy lifespan
• ​Strategy - Futurists, epidemiologists, social scientists, economists, bioethicists, and others thinking about how to harness emerging science behind Metabesity for global public health
• Academia - Instructors, administrators, students, and researchers across all fields of longevity, aging and Healthspan
• Communications - Journalists and marketing professionals who recognize hot topics and emerging trends
• The Interested Public

Read the Welcome Statement

What Our Attendees Say

​This was an excellent meeting from which I took many insights and learning in relation to metabesity and aging. A good networking opportunity.

The mix of science and critical information from government and industry and venture capitalist perspective was very interesting and informative.

I enjoyed learning about the science behind aging.
​
I was interested to hear the FDA perspective and the future need for pragmatic, randomized RWE trials.

Fantastic meeting, with excellent speaker selection. Enjoyed speakers’ diversity, from academia, industry, regulatory, and government.

Groundbreaking thoughtful, and fascinating.

One of the best meetings I’ve attended.

Ready to Register?

Register Here Free